Amantadine 193mg ER Tablets

Amantadine 193mg is an extended-release antiparkinsonian medicine used for Parkinson's disease and selected medicine-induced movement symptoms. This prolonged-release tablet family is distinct from conventional tablets and from bedtime extended-release capsules.
Take the extended-release tablet in the morning, with or without food. Swallow it whole; do not chew, crush or divide it. Kidney impairment can require less frequent dosing. It is not interchangeable milligram for milligram with other amantadine formulations.
Amantadine modifies dopamine signalling and blocks NMDA-type glutamate receptors. These actions can improve motor symptoms and reduce excessive excitatory signalling in movement-control pathways.
Dizziness, insomnia, nausea, dry mouth, ankle swelling and a mottled purple skin pattern can occur. Hallucinations, severe confusion, fainting or new compulsive behaviour need prompt assessment.
Drug accumulation is more likely with kidney impairment and in older adults. Tell your doctor about seizures, heart failure, hallucinations or glaucoma. Alcohol and sedating medicines can worsen confusion or dizziness. Sudden withdrawal may cause severe stiffness, fever or mental-state changes.
May ease movement-related disability as part of a Parkinson treatment plan. The response and tolerability determine whether it is useful alongside other motor-symptom medicines.
Yes. Livedo reticularis is a recognised effect of amantadine, sometimes with ankle swelling. Report a new persistent pattern, especially if swelling is also increasing.
New compulsive gambling, shopping, eating or sexual urges can occur. These changes may be easier for someone close to the patient to recognise.
The kidneys remove most of the medicine. A longer interval or lower amount may prevent accumulation, hallucinations and confusion.
No. Conventional and extended-release products differ in drug delivery and sometimes in how the strength is expressed. A planned conversion is needed.
Parkinsonism: slowness, stiffness or tremor related to dopamine-system dysfunction; NMDA receptor: a glutamate receptor involved in excitatory nerve signalling; Livedo reticularis: a mottled net-like skin pattern; Extrapyramidal symptoms: medicine-related movement abnormalities; Impulse-control disorder: difficulty resisting harmful repetitive urges; AR: Amantadine 193mg أقراص ممتدة التحرر; FR: Amantadine 193mg comprimés à libération prolongée; PT: Amantadine 193mg comprimidos de libertação prolongada; ES: Amantadine 193mg comprimidos de liberación prolongada; RU: Amantadine 193mg таблетки пролонгированного высвобождения; ID: Amantadine 193mg tablet lepas lambat; VI: Amantadine 193mg viên nén giải phóng kéo dài; MS: Amantadine 193mg tablet pelepasan berpanjangan; TL: Amantadine 193mg tabletang may pinalawig na paglabas; ZH-SG: Amantadine 193mg 缓释片
International B2B Enquiry
Send a structured B2B enquiry for Amantadine 193mg ER Tablets under Neuro Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Amantadine 193mg ER Tablets